Active 0 6 0 6 B-chronic_disease
serious 7 14 7 14 I-chronic_disease
infections 15 25 15 25 I-chronic_disease
not 26 29 26 29 O
controlled 30 40 30 40 O
by 41 43 41 43 O
antibiotics 44 55 44 55 B-treatment

Age 0 3 56 59 B-age
> 4 5 60 61 O
1 5 6 61 62 B-lower_bound
year 7 11 63 67 I-lower_bound
with 12 16 68 72 O
a 17 18 73 74 O
determination 19 32 75 88 O
that 33 37 89 93 O
radiation 38 47 94 103 O
safety 48 54 104 110 O
restrictions 55 67 111 123 O
during 68 74 124 130 O
therapy 75 82 131 138 B-treatment
period 83 89 139 145 O
can 90 93 146 149 O
be 94 96 150 152 O
implemented 97 108 153 164 O

Age 0 3 165 168 B-age
between 4 11 169 176 O
1 12 13 177 178 B-lower_bound
and 14 17 179 182 O
21 18 20 183 185 B-upper_bound
years 21 26 186 191 I-upper_bound
and 27 30 192 195 O
able 31 35 196 200 O
to 36 38 201 203 O
cooperate 39 48 204 213 O
with 49 53 214 218 O
radiation 54 63 219 228 B-treatment
safety 64 70 229 235 O
restrictions 71 83 236 248 O
during 84 90 249 255 O
therapy 91 98 256 263 B-treatment
period 99 105 264 270 O

At 0 2 271 273 O
least 3 8 274 279 O
2 9 10 280 281 B-lower_bound
weeks 11 16 282 287 I-lower_bound
should 17 23 288 294 O
have 24 28 295 299 O
elapsed 29 36 300 307 O
since 37 42 308 313 O
any 43 46 314 317 O
biologic 47 55 318 326 B-treatment
therapy 56 63 327 334 I-treatment

MIBG 0 4 335 339 B-treatment
- 4 5 339 340 O
avid 5 9 340 344 O
NB 10 12 345 347 B-cancer
and 13 16 348 351 O
evaluable 17 26 352 361 O
disease 27 34 362 369 O
on 35 37 370 372 O
MIBG 38 42 373 377 B-treatment
scan 43 47 378 382 I-treatment
at 48 50 383 385 O
time 51 55 386 390 O
of 56 58 391 393 O
enrollment 59 69 394 404 O
on 70 72 405 407 O
protocol 73 81 408 416 O

MIBG 0 4 417 421 B-treatment
- 4 5 421 422 O
avid 5 9 422 426 O
malignant 10 19 427 436 O
CCT 20 23 437 440 B-treatment
and 24 27 441 444 O
evaluable 28 37 445 454 O
disease 38 45 455 462 O
on 46 48 463 465 O
MIBG 49 53 466 470 B-treatment
scan 54 58 471 475 I-treatment
at 59 61 476 478 O
time 62 66 479 483 O
of 67 69 484 486 O
enrollment 70 80 487 497 O
on 81 83 498 500 O
protocol 84 92 501 509 O

Minimum 0 7 510 517 O
life 8 12 518 522 B-clinical_variable
expectancy 13 23 523 533 I-clinical_variable
of 24 26 534 536 O
eight 27 32 537 542 B-lower_bound
weeks 33 38 543 548 I-lower_bound

Pregnant 0 8 549 557 B-pregnancy
women 9 14 558 563 B-gender
are 15 18 564 567 O
excluded 19 27 568 576 O
for 28 31 577 580 O
fear 32 36 581 585 O
of 37 39 586 588 O
danger 40 46 589 595 O
to 47 49 596 598 O
the 50 53 599 602 O
fetus 54 59 603 608 O

Severe 0 6 609 615 O
major 7 12 616 621 O
organ 13 18 622 627 B-chronic_disease
toxicity 19 27 628 636 I-chronic_disease

Specifically 0 12 637 649 O
, 12 13 649 650 O
renal 14 19 651 656 B-chronic_disease
, 19 20 656 657 O
cardiac 21 28 658 665 B-chronic_disease
, 28 29 665 666 O
hepatic 30 37 667 674 B-chronic_disease
, 37 38 674 675 O
pulmonary 39 48 676 685 B-chronic_disease
, 48 49 685 686 O
gastrointestinal 50 66 687 703 B-chronic_disease
and 67 70 704 707 O
neurologic 71 81 708 718 B-chronic_disease
toxicity 82 90 719 727 I-chronic_disease
should 91 97 728 734 O
all 98 101 735 738 O
be 102 104 739 741 O
grade 105 110 742 747 B-upper_bound
2 111 112 748 749 I-upper_bound
or 113 115 750 752 O
less 116 120 753 757 O

Three 0 5 758 763 O
weeks 6 11 764 769 O
should 12 18 770 776 O
have 19 23 777 781 O
elapsed 24 31 782 789 O
since 32 37 790 795 O
last 38 42 796 800 O
dose 43 47 801 805 O
of 48 50 806 808 O
chemotherapy 51 63 809 821 B-treatment

diagnosis 0 9 822 831 O
of 10 12 832 834 O
malignant 13 22 835 844 B-cancer
CCT 23 26 845 848 I-cancer
i.e. 27 31 849 853 O
malignant 32 41 854 863 B-cancer
pheochromocytoma 42 58 864 880 I-cancer
or 59 61 881 883 O
malignant 62 71 884 893 B-cancer
paraganglioma 72 85 894 907 I-cancer

grade 0 5 908 913 B-chronic_disease
3 6 7 914 915 I-chronic_disease
hearing 8 15 916 923 I-chronic_disease
deficit 16 23 924 931 I-chronic_disease
is 24 26 932 934 O
acceptable 27 37 935 945 O

history 0 7 946 953 O
of 8 10 954 956 O
tumor 11 16 957 962 B-cancer
progression 17 28 963 974 O
or 29 31 975 977 O
recurrence 32 42 978 988 O
or 43 45 989 991 O
failure 46 53 992 999 O
to 54 56 1000 1002 O
achieve 57 64 1003 1010 O
complete 65 73 1011 1019 O
response 74 82 1020 1028 O
with 83 87 1029 1033 O
standard 88 96 1034 1042 B-treatment
therapy 97 104 1043 1050 I-treatment

ust 0 3 1051 1054 O
have 4 8 1055 1059 O
the 9 12 1060 1063 O
diagnosis 13 22 1064 1073 O
of 23 25 1074 1076 O
NB 26 28 1077 1079 B-cancer
in 29 31 1080 1082 O
accordance 32 42 1083 1093 O
with 43 47 1094 1098 O
the 48 51 1099 1102 O
International 52 65 1103 1116 O
Criteria 66 74 1117 1125 O
, 74 75 1125 1126 O
i.e. 76 80 1127 1131 O
, 80 81 1131 1132 O
either 82 88 1133 1139 O
histopathology 89 103 1140 1154 O
( 104 105 1155 1156 O
confirmed 105 114 1156 1165 O
by 115 117 1166 1168 O
the 118 121 1169 1172 O
MSKCC 122 127 1173 1178 O
Department 128 138 1179 1189 O
of 139 141 1190 1192 O
Pathology 142 151 1193 1202 O
) 151 152 1202 1203 O
or 153 155 1204 1206 O
BM 156 158 1207 1209 B-cancer
involvement 159 170 1210 1221 I-cancer
plus 171 175 1222 1226 O
elevated 176 184 1227 1235 O
urinary 185 192 1236 1243 B-chronic_disease
catecholamines 193 207 1244 1258 I-chronic_disease

